117 related articles for article (PubMed ID: 25391616)
1. Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer.
Douma KF; Meiser B; Kirk J; Mitchell G; Saunders C; Rahman B; Sousa MS; Barlow-Stewart K; Gleeson M; Tucker K
Fam Cancer; 2015 Jun; 14(2):265-72. PubMed ID: 25391616
[TBL] [Abstract][Full Text] [Related]
2. How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
Watts KJ; Meiser B; Mitchell G; Kirk J; Saunders C; Peate M; Duffy J; Kelly PJ; Gleeson M; Barlow-Stewart K; Rahman B; Friedlander M; Tucker K;
BMC Cancer; 2012 Jul; 12():320. PubMed ID: 22838957
[TBL] [Abstract][Full Text] [Related]
3. Oncology health professionals' attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer.
Burcher S; Meiser B; Mitchell G; Saunders C; Rahman B; Tucker K; Barlow-Stewart K; Watts K; Gleeson M; Kirk J
Per Med; 2013 Jul; 10(5):431-440. PubMed ID: 29758836
[TBL] [Abstract][Full Text] [Related]
4. Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.
Zilliacus E; Meiser B; Gleeson M; Watts K; Tucker K; Lobb EA; Mitchell G
Support Care Cancer; 2012 Nov; 20(11):2949-58. PubMed ID: 22441502
[TBL] [Abstract][Full Text] [Related]
5. Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
Meiser B; Gleeson M; Watts K; Peate M; Zilliacus E; Barlow-Stewart K; Saunders C; Mitchell G; Kirk J
Oncol Nurs Forum; 2012 Mar; 39(2):E101-11. PubMed ID: 22374498
[TBL] [Abstract][Full Text] [Related]
6. Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial.
Quinn VF; Meiser B; Kirk J; Tucker KM; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Cicciarelli L; Crowe K; Bowen MT; Mitchell G
Genet Med; 2017 Apr; 19(4):448-456. PubMed ID: 27684037
[TBL] [Abstract][Full Text] [Related]
7. Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer care.
Hallowell N; Wright S; Stirling D; Gourley C; Young O; Porteous M
Fam Cancer; 2019 Jul; 18(3):293-301. PubMed ID: 30689103
[TBL] [Abstract][Full Text] [Related]
8. Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing.
Gleeson M; Meiser B; Barlow-Stewart K; Trainer AH; Tucker K; Watts KJ; Friedlander M; Kasparian N
Oncol Nurs Forum; 2013 May; 40(3):275-83. PubMed ID: 23619104
[TBL] [Abstract][Full Text] [Related]
9. There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer.
Meiser B; Gleeson M; Kasparian N; Barlow-Stewart K; Ryan M; Watts K; Menon D; Mitchell G; Tucker K
Gynecol Oncol; 2012 Jan; 124(1):153-7. PubMed ID: 22032838
[TBL] [Abstract][Full Text] [Related]
10. When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer.
Meiser B; Quinn VF; Gleeson M; Kirk J; Tucker KM; Rahman B; Saunders C; Watts KJ; Peate M; Geelhoed E; Barlow-Stewart K; Field M; Harris M; Antill YC; Mitchell G
Eur J Hum Genet; 2016 Nov; 24(11):1517-1523. PubMed ID: 27329735
[TBL] [Abstract][Full Text] [Related]
11. Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making.
Wevers MR; Aaronson NK; Bleiker EMA; Hahn DEE; Brouwer T; van Dalen T; Theunissen EB; van Ooijen B; de Roos MA; Borgstein PJ; Vrouenraets BC; Vriens E; Bouma WH; Rijna H; Vente JP; Kuenen MA; van der Sanden-Melis J; Witkamp AJ; Rutgers EJT; Verhoef S; Ausems MGEM
J Surg Oncol; 2017 Dec; 116(8):1029-1039. PubMed ID: 28703900
[TBL] [Abstract][Full Text] [Related]
12. Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: The creation of an 'oncogenetic taskscape'.
Wright S; Porteous M; Stirling D; Young O; Gourley C; Hallowell N
Soc Sci Med; 2019 Mar; 225():26-33. PubMed ID: 30784848
[TBL] [Abstract][Full Text] [Related]
13. Patients' Views of Treatment-Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing.
Wright S; Porteous M; Stirling D; Lawton J; Young O; Gourley C; Hallowell N
J Genet Couns; 2018 May; 27(6):1459-72. PubMed ID: 29752676
[TBL] [Abstract][Full Text] [Related]
14. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
Ardern-Jones A; Kenen R; Eeles R
Eur J Cancer Care (Engl); 2005 Jul; 14(3):272-81. PubMed ID: 15952973
[TBL] [Abstract][Full Text] [Related]
15. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
17. Preoperative genetic testing affects surgical decision making in breast cancer patients.
Lokich E; Stuckey A; Raker C; Wilbur JS; Laprise J; Gass J
Gynecol Oncol; 2014 Aug; 134(2):326-30. PubMed ID: 24910453
[TBL] [Abstract][Full Text] [Related]
18. Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients.
Marino P; Siani C; Bertucci F; Roche H; Martin AL; Viens P; Seror V
Breast Cancer Res Treat; 2011 Sep; 129(2):401-9. PubMed ID: 21061059
[TBL] [Abstract][Full Text] [Related]
19. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
[TBL] [Abstract][Full Text] [Related]
20. Barriers to genetic testing in newly diagnosed breast cancer patients: Do surgeons limit testing?
Hafertepen L; Pastorino A; Morman N; Snow J; Halaharvi D; Byrne L; Cripe M
Am J Surg; 2017 Jul; 214(1):105-110. PubMed ID: 27773374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
